YARROW BIOSCIENCE, INC. Goodwill and Intangible Asset Impairment
YARROW BIOSCIENCE, INC. (YARW) reported Goodwill and Intangible Asset Impairment of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2022-03-17
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for the quarter ending 2021-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for the quarter ending 2021-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for the quarter ending 2021-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for fiscal 2020 was $54.34M.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for fiscal 2019 was $0.00.
- YARROW BIOSCIENCE, INC. goodwill and intangible asset impairment for fiscal 2018 was $0.00.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $54.34M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $54.34M derived: sum of 3 quarters · filed 2022-03-17 | $54.34M 10-K · filed 2022-03-17 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $54.34M derived: sum of 2 quarters · filed 2021-11-10 | $54.34M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $54.34M 10-Q · filed 2021-08-12 | $54.34M 10-Q · filed 2021-08-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |